ZA92862B - Lipoxygenase-inhibiting hydroxamic acid and N-hydroxyurea derivatives. - Google Patents

Lipoxygenase-inhibiting hydroxamic acid and N-hydroxyurea derivatives.

Info

Publication number
ZA92862B
ZA92862B ZA92862A ZA92862A ZA92862B ZA 92862 B ZA92862 B ZA 92862B ZA 92862 A ZA92862 A ZA 92862A ZA 92862 A ZA92862 A ZA 92862A ZA 92862 B ZA92862 B ZA 92862B
Authority
ZA
South Africa
Prior art keywords
hydrogen
hydroxamic acid
lipoxygenase
alkenyl
sulfur
Prior art date
Application number
ZA92862A
Other languages
English (en)
Inventor
Rodney William Stevens
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA92862B publication Critical patent/ZA92862B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/22—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Lubricants (AREA)
  • Pyrane Compounds (AREA)
  • Furan Compounds (AREA)
ZA92862A 1991-02-07 1992-02-06 Lipoxygenase-inhibiting hydroxamic acid and N-hydroxyurea derivatives. ZA92862B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3016325A JPH0730061B2 (ja) 1991-02-07 1991-02-07 ヒドロキサム酸誘導体および組成物

Publications (1)

Publication Number Publication Date
ZA92862B true ZA92862B (en) 1993-08-06

Family

ID=11913313

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA92862A ZA92862B (en) 1991-02-07 1992-02-06 Lipoxygenase-inhibiting hydroxamic acid and N-hydroxyurea derivatives.

Country Status (21)

Country Link
EP (1) EP0570401B1 (xx)
JP (1) JPH0730061B2 (xx)
KR (1) KR930703279A (xx)
AT (1) ATE113942T1 (xx)
AU (1) AU648872B2 (xx)
CA (1) CA2101539A1 (xx)
DE (1) DE69200665T2 (xx)
DK (1) DK0570401T3 (xx)
ES (1) ES2063578T3 (xx)
FI (1) FI933492A (xx)
HU (1) HUT65539A (xx)
IE (1) IE920392A1 (xx)
IL (1) IL100846A0 (xx)
MX (1) MX9200519A (xx)
MY (1) MY134478A (xx)
NO (1) NO932815L (xx)
NZ (1) NZ241530A (xx)
PT (1) PT100093A (xx)
TW (1) TW222627B (xx)
WO (1) WO1992013848A1 (xx)
ZA (1) ZA92862B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639782A (en) * 1992-03-04 1997-06-17 Center For Innovative Technology Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors
WO1994001430A1 (en) 1992-07-13 1994-01-20 Cytomed, Inc. 2,5-diaryl tetrahydro-thiophenes, -furans and analogs for the treatment of inflammatory and immune disorders
US5434151A (en) * 1992-08-24 1995-07-18 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5463083A (en) * 1992-07-13 1995-10-31 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
BR9508196A (pt) * 1994-06-27 1997-09-02 Cytomed Inc Composto uso de compostos composição farmacêutica e processo para tratamento de doenças inflamatórias em hospedeiro
US6201016B1 (en) * 1994-06-27 2001-03-13 Cytomed Incorporated Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5750565A (en) 1995-05-25 1998-05-12 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5792776A (en) * 1994-06-27 1998-08-11 Cytomed, Inc., Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5703093A (en) * 1995-05-31 1997-12-30 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
MX9701042A (es) * 1996-02-07 1998-05-31 Pfizer Compuestos del acido hidroxamico.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1044308A (en) * 1964-04-28 1966-09-28 Langbein Pfanhauser Werke Ag Electrodeposition of bright copper
US3393209A (en) * 1965-10-04 1968-07-16 Dow Chemical Co Furfuryl and tetrahydrofurfuryl phenyl ureas
JPS5742632B2 (xx) * 1972-12-25 1982-09-09
EP0279263B1 (en) * 1987-02-10 1993-08-04 Abbott Laboratories Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds
GB2201008B (en) * 1987-02-12 1991-10-23 Stc Plc Optical fibre cables

Also Published As

Publication number Publication date
DE69200665T2 (de) 1995-04-06
JPH04257571A (ja) 1992-09-11
HUT65539A (en) 1994-06-28
JPH0730061B2 (ja) 1995-04-05
AU1173692A (en) 1992-09-07
ES2063578T3 (es) 1995-01-01
MX9200519A (es) 1992-08-31
NZ241530A (en) 1994-06-27
NO932815L (no) 1993-08-09
MY134478A (en) 2007-12-31
IL100846A0 (en) 1992-11-15
KR930703279A (ko) 1993-11-29
FI933492A0 (fi) 1993-08-06
AU648872B2 (en) 1994-05-05
NO932815D0 (no) 1993-08-06
ATE113942T1 (de) 1994-11-15
IE920392A1 (en) 1992-08-12
DE69200665D1 (de) 1994-12-15
EP0570401B1 (en) 1994-11-09
PT100093A (pt) 1993-03-31
WO1992013848A1 (en) 1992-08-20
DK0570401T3 (da) 1994-12-05
FI933492A (fi) 1993-08-06
TW222627B (xx) 1994-04-21
CA2101539A1 (en) 1992-08-08
HU9302283D0 (en) 1993-10-28
EP0570401A1 (en) 1993-11-24

Similar Documents

Publication Publication Date Title
HU9502811D0 (en) N-acyl-sulfamic acid esters (or thioesters), n-acyl-sulfonamides and n-sulfonyl-carbamic-acid-esters (or thioesters) as hypercholesterolemic agents
HUT67436A (en) Process to prepare novel hydroxamic acid and n-hydroxyurea derivatives and pharmaceutical compn.s contg. them
DE69416501D1 (de) 2-propylvaleriansäure und 2-propylvalerian-säureamid-derivate und deren verwendung als antikonvulsive mittel
CA2103590A1 (en) Benzamide derivative
HUT75111A (en) Use of pyridyl-,oxadiazole or thiadiazole derivatives for producing pharmaceutical compositions having effect
TW222627B (xx)
CA2174544A1 (en) Method for using pharmaceutical compositions containing 2-(2-alkylphenylamino)-oxazolines, 2-(2-alkylphenyl-amino)-thiazolines and 2-(2-alkylphenylamino)-imidazolines as adrenergic agents
DE68917772D1 (de) 2-Alkyl-3-benzoylbenzofurane und diese enthaltende pharmazeutische Zusammensetzungen.
HU9201033D0 (en) Tiazolidinone- and oxazolidinone derivatives, process for their production, and for the production of medical preparations containing them as active agents
ZA984114B (en) Substituted heterocyclic compounds a process for the preparation thereof and pharmaceutical compositions containing them
DE69411003D1 (de) Cycloalkylhydroxyharnstoffe und ihre verwendung als lipoxy-genase-inhibitoren
CA2140344A1 (en) Antiinflammatory Indolinyl N-Hydroxyurea and N-Hydroxamic Acid Derivatives
GR3025692T3 (en) Phenyl substituted cycloalkyl hydroxyurea derivatives which inhibit lipoxygenase.
HUT54688A (en) Process for producing compounds utilizable for treating ulcus and pharmaceutical compositions containing them as active components
WO2001035938A3 (de) Pharmakologisch aktive tetrahydrothiopyran-4-ol-derivate, verfahren zu ihrer herstellung und verwendung